Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

Hadassah Medical Organization250 enrolled

Overview

The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Epilepsy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER) * Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.

Locations (1)

Hadassah Ein-Kerem Medical Center

Jerusalem, Israel

RECRUITING

Central Contacts

Dana Ekstein, MD

CONTACT

dekstein@md.huji.ac.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.